Product Images Acyclovix

Acyclovir Capsules USP, RxOnIy, contain 200 mg of Acyclovir USP. Please refer to the package insert for complete prescribing information and dosage instructions. These capsules should be stored in a tightly closed container at a temperature of 20°C to 25°C and protected from light and moisture. This product is manufactured and distributed by Carlsbad Tech, located in Carlsbad, CA92008 USA. NDC number is 61442-114-01.*

Table 1 shows the pharmacokinetic characteristics of Acyclovir, including plasma protein binding, plasma elimination half-life, and average oral bioavailability. The range of plasma protein binding is from 9% to 1033%. The range of plasma elimination half-life is from 25 to 1033 hours. The average oral bioavailability ranges from 10% to 20%, but bioavailability decreases with increasing dose.*

This is a table presenting the Acyclovir Peak and Trough Concentrations at Steady State for three different doses: 200 mg, 400 mg, and 800 mg. The table shows the values in units of microliters per milliliter (meg/mL).*

This is a dosage modification table for patients with renal impairment. It shows the normal dosage, adjusted dosage regimen, and dosing intervals for different creatinine clearance levels. The table includes the dosage adjustments for 200 mg, 400 mg, and 800 mg medication dosages. The dosing intervals range from every four hours to every 12 hours based on the creatinine clearance level.*